Why is the Bubs share price on ice today?

Bubs shares aren't trading today. Could we be looking at a capital raise?

| More on:
A man peers out from a high collared jacket with just his eyes and nose visible amid a swirling snowstorm.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a pretty nasty start to the trading week for ASX shares and the All Ordinaries Index (ASX: XAO) so far this Monday. The ASX seems to be suffering from some Monday-itis today, with the All Ords currently down by a significant 1.27%.

But one All Ords share – Bubs Australia Ltd (ASX: BUB) – isn't joining the pity party just yet.

Bubs shares closed at 28 cents each last week. And that's where the ASX dairy company will be staying, at least for a while. While the ASX is falling today, Bubs shares are (perhaps mercifully) frozen at 28 cents each.

This morning, just before market open, Bubs released an ASX announcement to the markets. This informed investors that the Bus share price would be suspended from trading.

Here's what the statement said in full:

Trading in the securities of the entity will be temporarily paused pending a further announcement.

And that's it. That's all we know for now.

So why is the Bubs share price frozen today?

So what might be going on with Bubs today? Well, it's really not clear. However, Bubs shares have been under pressure ever since the company's latest quarterly update was made public at the end of January.

As we covered at the time, this saw Bubs report revenues of $14.3 million for the three months ending 31 December 2022. That was a 28% drop from what the company reported last year. Half-year revenues also slid, but only by 1% to $37.9 million.

Cash outflows came in at $13.5 million for the quarter, which reduced the company's cash balance from $64.6 million to $51.4 million.

Upon the release of this update, the Bubs share price cratered by a nasty 11.11%. The company has now fallen almost 21% from where it was before this report was released at today's pricing:

So perhaps today's announcement could relate to a capital raising program or some other measure to boost Bubs' balance sheet. Or it could be something else. We'll just have to wait and see what Bubs pulls out of its hat. Watch this space.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Bubs Australia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two excited woman pointing out a bargain opportunity on a laptop.
Share Gainers

3 ASX 200 stocks jumping higher in this week's falling market

Investors shrugged off the broader market retrace and piled into these three ASX 200 stocks this week.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why EOS, Lotus Resources, REA, and Web Travel shares are dropping today

These shares are ending the week deep in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today

These shares are avoiding the selloff and are pushing higher on Friday.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Share Fallers

Why is the Web Travel share price crashing 41% on Friday?

ASX investors are pummelling Web Travel shares today. But why?

Read more »

A man looking at his laptop and thinking.
Materials Shares

Rio Tinto shares charge higher after Glencore merger collapses

The parties couldn't come to an agreement.

Read more »

a group of doctors and medical staff in uniform high five in celebration in a hospital setting
Share Market News

Neuren Pharmaceuticals kicks off Phase 3 trial in rare syndrome

Neuren Pharmaceuticals shares are on watch after dosing began in its key Phase 3 trial for Phelan-McDermid syndrome.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Top broker forecasts another 83% upside for this outperforming ASX All Ords tech stock

A leading broker expects outsized gains from this ASX All Ords tech stock in 2026. But why?

Read more »

ASX share investor holding up hand in stop motion
Share Market News

Rio Tinto confirms no merger with Glencore after review

Rio Tinto has announced it won't pursue a merger with Glencore, reaffirming its focus on long-term value for shareholders.

Read more »